Patent · US Active

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway

US8110578B2 · kind B2 · utility

39Cited by
14References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 26, 2009
Grant dateFeb 7, 2012
Priority date—
Expiry dateOct 26, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Heteroaryl Compounds having the following structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.